Showing results (1-10 of 96) with videos related to
Sort By:
Pageof 10
Cancers|July 9, 2022
Testing for Dihydropyrimidine Dehydrogenase Deficiency to Individualize 5-Fluorouracil TherapyRobert B Diasio, Steven M OfferClinical Pharmacology and Therapeutics|June 11, 2021
Pharmacogenomic-Guided Therapy in Colorectal CancerRobert B Diasio, Federico Innocenti, Steven M OfferCancer Research|January 19, 2013
Phenotypic profiling of DPYD variations relevant to 5-fluorouracil sensitivity using real-time cellular analysis and in vitro measurement of enzyme activitySteven M Offer, Natalie J Wegner, Croix Fossum, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2015
Polymorphisms in MIR27A Associated with Early-Onset Toxicity in Fluoropyrimidine-Based ChemotherapyUrsula Amstutz, Steven M Offer, Johanna Sistonen, et al.Journal of the National Cancer Center|July 22, 2024
Chromatin assembly factor 1 suppresses epigenetic reprogramming toward adaptive drug resistanceZhiquan Wang, Rentian Wu, Qian Nie, et al.Mayo Clinic Proceedings|January 7, 2014
A DPYD variant (Y186C) specific to individuals of African descent in a patient with life-threatening 5-FU toxic effects: potential for an individualized medicine approachM Wasif Saif, Adam M Lee, Steven M Offer, et al.Clinical Pharmacology and Therapeutics|January 13, 2018
Gene-Specific Variant Classifier (DPYD-Varifier) to Identify Deleterious Alleles of Dihydropyrimidine DehydrogenaseShikshya Shrestha, Cheng Zhang, Calvin R Jerde, et al.Cancer Research|March 21, 2014
Comparative functional analysis of DPYD variants of potential clinical relevance to dihydropyrimidine dehydrogenase activitySteven M Offer, Croix C Fossum, Natalie J Wegner, et al.Molecular Cancer Therapeutics|January 10, 2014
microRNAs miR-27a and miR-27b directly regulate liver dihydropyrimidine dehydrogenase expression through two conserved binding sitesSteven M Offer, Gabriel L Butterfield, Calvin R Jerde, et al.Journal of Personalized Medicine|October 22, 2020
A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic StudiesDominic Schaerer, Tanja K Froehlich, Seid Hamzic, et al.Pageof 10